Differential effects of reduced cyclic stretch and perturbed shear stress within the arterial wall and on smooth muscle function

American Journal of Hypertension

Volumn 22, Issue 12, 2009, Pages 1250-1257

  Thacher, Tyler ^a   Da Silva, Rafaela F ^a,b,c   Stergiopulos, Nikos ^a  

^a EPFL   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; GELATINASE; PROTEIN P22; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY MUSCLE; ARTICLE; MUSCLE CONTRACTILITY; MUSCLE FUNCTION; MYOTATIC REFLEX; NONHUMAN; OSCILLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHEAR STRESS; SWINE;

ANIMALS; CAROTID ARTERIES; COMPLIANCE; FIBRONECTINS; GELATINASES; MATRIX METALLOPROTEINASE 2; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; NADPH OXIDASE; PERFUSION; STRESS, MECHANICAL; SUPEROXIDES; SWINE;

EID: 70450222518     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2009.193     Document Type: Article

References (27)

1. Segers D, Helderman F, Cheng C, van Damme LC, Tempel D, Boersma E, Serruys PW, de Crom R, van der Steen AF, Holvoet P, Krams R. Gelatinolytic activity in atherosclerotic plaques is highly localized and is associated with both macrophages and smooth muscle cells in vivo. Circulation 2007; 115: 609-616.
2. Riccioni G. Statins and carotid intima-media thickness reduction: an up-to-date review. Curr Med Chem 2009; 16:1799-1805.
3. Baldassarre D, Amato M, Bondioli A, Sirtori CR, Tremoli E. Carotid artery intima-media thickness measured by ultrasonography in normal clinical practice correlates well with atherosclerosis risk factors. Stroke 2000; 31: 2426-2430.
4. Gambillara V, Montorzi G, Haziza-Pigeon C, Stergiopulos N, Silacci P. Arterial wall response to ex vivo exposure to oscillatory shear stress. J Vasc Res 2005; 42:535-544.
5. Gambillara V, Thacher T, Silacci P, Stergiopulos N. Effects of reduced cyclic stretch on vascular smooth muscle cell function of pig carotids perfused ex vivo. Am J Hypertens 2008; 21:425-431.
6. Prado CM, Ramos SG, Alves-Filho JC, Elias J Jr, Cunha FQ, Rossi MA. Turbulent flow/low wall shear stress and stretch differentially affect aorta remodeling in rats. J Hypertens 2006; 24:503-515.
7. Paravicini TM, Touyz RM. Redox signaling in hypertension. Cardiovasc Res 2006; 71:247-258.
8. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007; 39:44-84.
9. Abbruzzese TA, Guzman RJ, Martin RL, Yee C, Zarins CK, Dalman RL. Matrix metalloproteinase inhibition limits arterial enlargements in a rodent arteriovenous fistula model. Surgery 1998; 124:328-334; discussion 334-335.
10. Chiang HY, Korshunov VA, Serour A, Shi F, Sottile J. Fibronectin is an important regulator of flow-induced vascular remodeling. Arterioscler Thromb Vasc Biol 2009; 29:1074-1079.
11. Montorzi G, Silacci P, Zulliger M, Stergiopulos N. Functional, mechanical and geometrical adaptation of the arterial wall of a non-axisymmetric artery in vitro. J Hypertens 2004; 22:339-347.
12. Oliver JJ, Webb DJ. Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscler Thromb Vasc Biol 2003; 23:554-566.
13. Caro CG. Discovery of the role of wall shear in atherosclerosis. Arterioscler Thromb Vasc Biol 2009; 29:158-161.
14. Touyz RM, Schiffrin EL. Reactive oxygen species in vascular biology: implications in hypertension. Histochem Cell Biol 2004; 122:339-352.
15. Touyz RM. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 2004; 44:248-252.
16. Tsutsui M, Shimokawa H, Otsuji Y, Ueta Y, Sasaguri Y, Yanagihara N. Nitric oxide synthases and cardiovascular diseases: insights from genetically modified mice. Circ J 2009; 73:986-993.
17. Sonoyama K, Greenstein A, Price A, Khavandi K, Heagerty T. Vascular remodeling: implications for small artery function and target organ damage. Ther Adv Cardiovasc Dis 2007; 1:129-137.
18. Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 2005; 25:932-943.
19. Matlung HL, Bakker EN, Vanbavel E. Shear stress, reactive oxygen species and arterial structure and function. Antioxid Redox Signal 2009; e-pub ahead of print 2 Feb 2009.
20. Skyschally A, Schulz R, Gres P, Korth HG, Heusch G. Attenuation of ischemic preconditioning in pigs by scavenging of free oxyradicals with ascorbic acid. Am J Physiol Heart Circ Physiol 2003; 284:H698-H703.
21. Chen W, Gabel S, Steenbergen C, Murphy E. A redox-based mechanism for cardioprotection induced by ischemic preconditioning in perfused rat heart. Circ Res 1995; 77:424-429.
22. Sedeek M, Hébert RL, Kennedy CR, Burns KD, Touyz RM. Molecular mechanisms of hypertension: role of Nox family NADPH oxidases. Curr Opin Nephrol Hypertens 2009; 18:122-127.
23. Violi F, Basili S, Nigro C, Pignatelli P. Role of NADPH oxidase in atherosclerosis. Future Cardiol 2009; 5:83-92.
24. Cave A. Selective targeting of NADPH oxidase for cardiovascular protection. Curr Opin Pharmacol 2009; 9:208-213.
25. Thacher T, Silacci P, Stergiopulos N, da Silva RF. Autonomous effects of shear stress and cyclic circumferential stretch regarding endothelial dysfunction and oxidative stress: an ex-vivo arterial model. J Vasc Res, in press.
26. Lehoux S, Castier Y, Tedgui A. Molecular mechanisms of the vascular responses to haemodynamic forces. J Intern Med 2006; 259:381-392.
27. Astrof S, Hynes RO. Fibronectins in vascular morphogenesis. Angiogenesis 2009; 12:165-175.